DOCSLIB.ORG

BREATHLESSNESS ABSTRACT INTRODUCTION Dyspnoea, Also

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
BREATHLESSNESS ABSTRACT INTRODUCTION Dyspnoea, Also EMERGENCY MEDICINE – WHAT THE FAMILY PHYSICIAN CAN TREAT UNIT NO. 4 BREATHLESSNESS In one study of 85 patients presenting to a pulmonary unit Psychiatric conditions appropriate context of the history, physical examination, and ischaemia. Serial measurements of cardiac biomarkers are inhaler (MDI). In severe asthma, patients should be transferred breathlessness. In such cases, it is prudent to start therapies for with a complaint of chronic dyspnoea, the initial impression Psychogenic causes for acute dyspnoea is a diagnosis of the consideration of dierential diagnosis. Random testing necessary as initial results can often be normal. to ED for further treatment with nebulised ipratropium multiple conditions in the initial resuscitative phase. For Dr Pothiawala Sohil of the aetiology of dyspnoea based upon the patient history exclusion, and organic causes must be ruled out rst before without a clear dierential diagnosis will delay appropriate bromide, intravenous magnesium, ketamine, IM adrenaline, example, for a patient with a past medical history of COPD and alone was correct in only 66 percent of cases.4 us, a considering this diagnosis (e.g., panic attack).5 management. e use of dyspnoea biomarker panels does not Brain natriuretic peptide (BNP) intubation, and inhalational anaesthesia as needed. congestive cardiac failure, the initial management of sudden systematic approach, comprising of adequate history and appear to improve accuracy beyond clinical assessment and is is used to diagnose heart failure, but it can also be elevated onset of dyspnoea may include therapies directed at both these ABSTRACT diagnostic studies, and provide recommendations for initial physical examination, followed by appropriate investigations focused testing.6, 7 in uid overload secondary to renal failure. BNP testing is not COPD exacerbation conditions. After initial stabilisation, the nal disposition of the Breathlessness, also known as dyspnoea, is a common management and disposition. presenting complaint in the outpatient family physician clinic. is necessary. PHYSICAL EXAMINATION helpful when used indiscriminately in patients with acute Patients with mild exacerbation are treated with nebulised patient depends on your consideration of the dierential It is most commonly caused by respiratory and cardiac Blood tests dyspnea.10, 11 salbutamol, ipratropium and steroids. Antibiotics are indicated diagnosis. Unstable patients should be transported to the disorders, but there are lots of other important aetiologies Signs that suggest severe respiratory distress include e initial evaluation usually includes measurement of if there is evidence of an infective process suggested by fever, emergency department for further evaluation and treatment. that need to be considered. The initial goal of assessment is to EPIDEMIOLOGY HISTORY tachypnoea/bradypnoea, retractions, use of accessory muscles, haemoglobin (to exclude anaemia as a cause of dyspnoea), D-Dimer increased sputum production, or purulent sputum. Patients Patients who are stable should be discharged with appropriate determine the severity of the dyspnoea, considering the need inability to speak in full sentences, inability to lie supine or in for oxygen therapy and intubation. Unstable patients usually A chief complaint of dyspnoea or shortness of breath made up blood glucose (to rule out Kussmaul’s breathing secondary to Patients at low risk for PE according to a validated scoring with moderate to severe respiratory distress should be sent to medications and advised to return back if their condition a tripod position, diaphoresis, agitation or altered mental present with abnormal vital signs, hypoxia, diaphoresis, and/or 3.5 percent of the more than 115 million visits to United States e history forms a critical component in the evaluation of the diabetic ketoacidosis), urea, creatinine and electrolytes. system (Wells criteria for PE, PERC rule) and a negative ED for further management, which can include non-invasive persists or worsens. status, and cyanosis. altered mental states, and require urgent management. EDs in 2003. Other dyspnoea-related chief complaints (cough, dyspnoeic patient, but can be dicult to obtain when the d-dimer can be ruled out for PE without further testing. It ventilation (BiPAP) or endotracheal intubation. Ongoing care depends on the differential diagnosis established chest discomfort) comprised 7.6 percent.2 patient has diculty speaking. Relevant history can be Chest X-ray cannot be used as a rule-out test in patients with moderate to by an adequate history and physical examination, and obtained from the patient, paramedics, family, and caretakers. Retractions occur with airway obstruction (e.g., asthma, e chest radiograph may provide clues to the cause of high pre-test probability of PE. Pneumonia CONCLUSION investigations, if available, can aid definitive diagnosis. The COPD, foreign body) and can be seen in the suprasternal, dysnoea. Patients who are low risk using the CURB-65 score should be family physicians must be equipped to initiate appropriate According to one prospective observational study, the most Present history intercostal, and subcostal areas. ey are an ominous sign e family physicians must be equipped to perform an initial therapy, conduct continuous monitoring and stabilise an common diagnoses among elderly patients presenting to an Arterial and venous blood gas commenced on appropriate antibiotic therapy as per the local suggesting extreme respiratory distress. e use of accessory acutely dyspnoeic patient before determining the final ED with a complaint of acute shortness of breath and Enquire regarding the symptoms, duration, severity, onset - Signs of Acute heart failure are cardiomegaly, cephalisation of e role of the arterial blood gas (ABG) in the diagnosis and antibiotic guidelines and discharged with follow-up within 5-7 assessment, initiate appropriate therapy and stabilise an acutely muscles to breathe suggests fatigue of the respiratory muscles disposition of the patient. manifesting signs of respiratory distress (e.g., respiratory rate whether it is sudden or gradual. Acute dyspnoea following a blood vessels, interstitial oedema ( "Kerley B" lines) and treatment of the acutely dyspnoeic patient is limited. Venous days for re-assessment. Patients with moderate to high risk dyspnoeic patient before determining the disposition of the and a potential for respiratory failure. Diaphoresis reects >25, SpO <93%) are decompensated heart failure, meal or medication suggests an allergic reaction; a new pulmonary vascular congestion. Pleural eusion may be blood gas can be used as an alternate to determine the acid-base should be referred to the hospital for admission and further patient, either discharging home or referring to the emergency Keywords: 2 productive cough suggests chest infection; viral infection or extreme sympathetic stimulation associated with severity of department for further management. pneumonia, chronic obstructive pulmonary disease, present. Around 20 percent of patients admitted with acute status. e PaCO2 levels are low in a breathless patient due to management. In severe pneumonia, 3rd-generation Breathlessness, Dyspnoea, Family Physician, Differential 8 3 allergen exposure can trigger asthma; recent surgery, disease process (myocardial infarction, severe asthma, heart failure may have a non-diagnostic CXR. hyperventilation. A normal or elevated CO in a breathless cephalosporin (ceftriaxone) with a macrolide (azithromycin) is Diagnosis, Management pulmonary embolism, and asthma. 2 immobilisation or long travel time increases the risk for pulmonary oedema). Altered mental status suggests severe patient suggests respiratory failure. the rst-line treatment. In patients with penicillin allergy, a REFERENCES 1. Parshall MB, Schwartzstein RM, Adams L, et al. An official American pulmonary embolism (PE); and trauma may cause hypoxia or hypercarbia, but may also be caused by underlying - Inltrates on CXR are considered the “gold standard” for uoroquinolone should be used. SFP2015; 41(3): 24-29 PATHOPHYSIOLOGY Thoracic Society statement: update on the mechanisms, assessment, pneumothorax or pulmonary contusion. Noncompliance with pathology (e.g., hypoglycaemia, sepsis, poisoning). Cyanosis is diagnosing pneumonia. But X-rays obtained early in the CT orax and management of dyspnea. Am J Respir Crit Care Med. 2012 Feb a late sign and indicates severe hypoxia. 9 e respiratory system is designed to maintain homeostasis medications or increased uid intake may lead to acute clinical course of illness may be non-diagnostic. Also, the A multi-detector computed tomography (MDCT) scan of the Acute Pulmonary Oedema 15;185(4):43552. INTRODUCTION with respect to gas exchange and acid-base status. decompensated heart failure. appearance of the CXR (lobar versus diuse) does not thorax is not indicated in the initial evaluation, but can aid Intravenous frusemide along with sublingual nitroglycerine 2. American College of Emergency Physicians. Vital signs include temperature, heart rate, respiratory rate www.acep.org/webportal/Newsroom/NewsMediaResources/Statistics Derangements in oxygenation, ventilation and acidaemia can accurately predict the aetiology of the pneumonia (typical diagnosis of PE, malignancy, etc. MDCT entails complications tablets/spray should be commenced in the clinic. ey should Dyspnoea, also known as shortness of breath, is one of the Past history and pulse oximetry. Patients with serious underlying disease versus atypical).
Load more

Recommended publications
  • Differentiating Between Anxiety, Syncope & Anaphylaxis
    Differentiating between anxiety, syncope & anaphylaxis Dr. Réka Gustafson Medical Health Officer Vancouver Coastal Health Introduction Anaphylaxis is a rare but much feared side-effect of vaccination. Most vaccine providers will never see a case of true anaphylaxis due to vaccination, but need to be prepared to diagnose and respond to this medical emergency. Since anaphylaxis is so rare, most of us rely on guidelines to assist us in assessment and response. Due to the highly variable presentation, and absence of clinical trials, guidelines are by necessity often vague and very conservative. Guidelines are no substitute for good clinical judgment. Anaphylaxis Guidelines • “Anaphylaxis is a potentially life-threatening IgE mediated allergic reaction” – How many people die or have died from anaphylaxis after immunization? Can we predict who is likely to die from anaphylaxis? • “Anaphylaxis is one of the rarer events reported in the post-marketing surveillance” – How rare? Will I or my colleagues ever see a case? • “Changes develop over several minutes” – What is “several”? 1, 2, 10, 20 minutes? • “Even when there are mild symptoms initially, there is a potential for progression to a severe and even irreversible outcome” – Do I park my clinical judgment at the door? What do I look for in my clinical assessment? • “Fatalities during anaphylaxis usually result from delayed administration of epinephrine and from severe cardiac and respiratory complications. “ – What is delayed? How much time do I have? What is anaphylaxis? •an acute, potentially
    [Show full text]
  • (Loxapine) REMS
    Current as of 6/1/2013.® This document may not be part of the latest approved REMS. Alexza Pharmaceuticals, Inc. 2091 Stierlin Court, Mountain View, CA 94043 IMPORTANT DRUG WARNING Risk of bronchospasm with ADASUVE™ (loxapine) inhalation powder ADASUVE™ available only in enrolled healthcare facilities, under an FDA-required REMS Program Dear Healthcare Professional: This letter contains important safety information for ADASUVE™ (loxapine) Inhalation Powder. ADASUVE is a drug-device combination product that delivers the antipsychotic, loxapine, by oral inhalation. ADASUVE has been approved by the US Food and Drug Administration (FDA) for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. FDA has determined that a Risk Evaluation and Mitigation Strategy (REMS) is necessary to ensure that the benefits of treatment outweigh the risk of bronchospasm in patients treated with ADASUVE. ADASUVE is not available in an outpatient setting. If you are an outpatient provider, you are receiving this letter because ADASUVE may be, or may have been, administered to one of your patients in an enrolled healthcare facility. Enrolled healthcare facilities, such as an acute care or inpatient setting, must have immediate on-site access to equipment and personnel trained to manage acute bronchospasm, including advanced airway management, eg, intubation and mechanical ventilation. (See below for more facility enrollment requirements.) It is important that anyone caring for patients treated with ADASUVE be aware of the risk of bronchospasm after administration. This letter does not contain a complete list of all the risks associated with ADASUVE. Reference ID:Please 3235446 see the enclosed full prescribing information for more information.
    [Show full text]
  • Slipping Rib Syndrome
    Slipping Rib Syndrome Jackie Dozier, BS Edited by Lisa E McMahon, MD FACS FAAP David M Notrica, MD FACS FAAP Case Presentation AA is a 12 year old female who presented with a 7 month history of right-sided chest/rib pain. She states that the pain was not preceded by trauma and she had never experienced pain like this before. She has been seen in the past by her pediatrician, chiropractor, and sports medicine physician for her pain. In May 2012, she was seen in the ER after having manipulations done on her ribs by a sports medicine physician. Pain at that time was constant throughout the day and kept her from sleeping. However, it was relieved with hydrocodone/acetaminophen in the ER. Case Presentation Over the following months, the pain became progressively worse and then constant. She also developed shortness of breath. She is a swimmer and says she has had difficulty practicing due to the pain and SOB. AA was seen by a pediatric surgeon and scheduled for an interventional pain management service consult for a test injection. Following good temporary relief by local injection, she was scheduled costal cartilage removal to treat her pain. What is Slipping Rib Syndrome? •Slipping Rib Syndrome (SRS) is caused by hypermobility of the anterior ends of the false rib costal cartilages, which leads to slipping of the affected rib under the superior adjacent rib. •SRS an lead to irritation of the intercostal nerve or strain of the muscles surrounding the rib. •SRS is often misdiagnosed and can lead to months or years of unresolved abdominal and/or thoracic pain.
    [Show full text]
  • Signs and Symptoms of COPD
    American Thoracic Society PATIENT EDUCATION | INFORMATION SERIES Signs and Symptoms of COPD Chronic obstructive pulmonary disease (COPD) can cause shortness of breath, tiredness, Short ness of Breath production of mucus, and cough. Many people with COPD develop most if not all, of these signs Avo iding Activities and symptoms. Sho rtness wit of Breath h Man s Why is shortness of breath a symptom of COPD? y Activitie Shortness of breath (or breathlessness) is a common Avoiding symptom of COPD because the obstruction in the A breathing tubes makes it difficult to move air in and ny Activity out of your lungs. This produces a feeling of difficulty breathing (See ATS Patient Information Series fact sheet Shor f B tness o on Breathlessness). Unfortunately, people try to avoid this reath Sitting feeling by becoming less and less active. This plan may or Standing work at first, but in time it leads to a downward spiral of: avoiding activities which leads to getting out of shape or becoming deconditioned, and this can result in even more Is tiredness a symptom of COPD? shortness of breath with activity (see diagram). Tiredness (or fatigue) is a common symptom in COPD. What can I do to treat shortness of breath? Tiredness may discourage you from keeping active, which leads to greater loss of energy, which then leads to more If your shortness of breath is from COPD, you can do several tiredness. When this cycle begins it is sometimes hard to things to control it: break. CLIP AND COPY AND CLIP ■■ Take your medications regularly.
    [Show full text]
  • Inhaled Loxapine Monograph
    Inhaled Loxapine Monograph Inhaled Loxapine (ADASUVE) National Drug Monograph February 2015 VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives The purpose of VA PBM Services drug monographs is to provide a comprehensive drug review for making formulary decisions. Updates will be made when new clinical data warrant additional formulary discussion. Documents will be placed in the Archive section when the information is deemed to be no longer current. FDA Approval Information Description/Mechanism of Inhaled loxapine is a typical antipsychotic used in the treatment of acute Action agitation associated with schizophrenia and bipolar I disorder in adults. Loxapine’s mechanism of action for reducing agitation in schizophrenia and bipolar I disorder is unknown. Its effects are thought to be mediated through blocking postsynaptic dopamine D2 receptors as well as some activity at the serotonin 5-HT2A receptors. Indication(s) Under Review in Inhaled loxapine is a typical antipsychotic indicated for the acute treatment of this document (may include agitation associated with schizophrenia or bipolar I disorder in adults. off label) Off-label use Agitation related to any other cause not due to schizophrenia and bipolar I disorder. Dosage Form(s) Under 10mg oral inhalation using a new STACCATO inhaler device. Review REMS REMS No REMS Post-marketing Study Required See Other Considerations for additional REMS information Pregnancy Rating C Executive Summary Efficacy Inhaled loxapine was superior to placebo in reducing acute agitation at 2 hours post dose measured by the Positive and Negative Syndrome Scale-Excited Component (PEC) in patients with bipolar I disorder and schizophrenia.
    [Show full text]
  • Beta Adrenergic Agents
    Beta2 Adrenergic Agents –Long Acting Review 04/10/2008 Copyright © 2007 - 2008 by Provider Synergies, L.L.C. All rights reserved. Printed in the United States of America. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, digital scanning, or via any information storage and retrieval system without the express written consent of Provider Synergies, L.L.C. All requests for permission should be mailed to: Attention: Copyright Administrator Intellectual Property Department Provider Synergies, L.L.C. 5181 Natorp Blvd., Suite 205 Mason, Ohio 45040 The materials contained herein represent the opinions of the collective authors and editors and should not be construed to be the official representation of any professional organization or group, any state Pharmacy and Therapeutics committee, any state Medicaid Agency, or any other clinical committee. This material is not intended to be relied upon as medical advice for specific medical cases and nothing contained herein should be relied upon by any patient, medical professional or layperson seeking information about a specific course of treatment for a specific medical condition. All readers of this material are responsible for independently obtaining medical advice and guidance from their own physician and/or other medical professional in regard to the best course of treatment for their specific medical condition. This publication, inclusive of all forms contained herein, is intended to be educational in nature and is intended to be used for informational purposes only. Comments and suggestions may be sent to [email protected].
    [Show full text]
  • Breathing Better with a COPD Diagnosis
    Difficulty Breathing Chronic Bronchitis Smoker’s Cough Chronic Coughing Wheezing Em- Chronic Obstructive Pulmonary Disease physema Shortness of Breath Feeling of Suffocation Excess Mucus Difficulty Breathing Chronic Bronchitis Smoker’s Cough Chronic Coughing Wheezing Emphysema Shor tness of Breath Feeling of Suffocation Excess Mucus Difficulty Breathing Chronic Bronchitis Smoker’s Cough Chronic Coughing Wheezing Emphysema Shortness of Breath Feeling of Suffocation Excess Mucus Difficulty Breathing Chronic Bronchitis Smoker’s Cough Chron- ic Coughing Wheezing Emphysema Shortness of Breath Feeling of Suffocation Excess Mu- cus DifficultyBreathing Breathing Chronic Bronchitis Better Smoker’s Cough Chronic Coughing Wheezing Emphysema Shortness of Breath Feeling of Suffocation Excess Mucus Difficulty Breathing Chronic Bronchitis Smoker’s Cough Chronic Coughing Wheezing Emphysema Shor tness of Breath Feeling of SuffocationWith Excess a COPDMucus Difficulty Diagnosis Breathing Chronic Bronchitis Smoker’s Cough Chronic Coughing Wheezing Emphysema Shortness of Breath Feeling of did you know? When COPD is severe, shortness of breath and other COPDdid you is the know? 4th leading cause of death in the symptomswhen you can get are in the diagnosed way of doing even the most UnitedCOPD States.is the 4th The leading disease cause kills ofmore death than in 120,000 basicwith tasks, copd such as doing light housework, taking a Americansthe United eachStates year—that’s and causes 1 serious, death every long-term 4 walk,There and are even many bathing things and that getting you can dressed. do to make minutes—anddisability. The causesnumber serious, of people long-term with COPDdisability. is COPDliving withdevelops COPD slowly, easier: and can worsen over time, increasing.The number More of people than 12with million COPD people is increasing.
    [Show full text]
  • Rivaroxaban (Xarelto®)
    Rivaroxaban (Xarelto®) To reduce your bleeding and clotting risk it is important that you attend follow-up appointments with your provider, and have blood tests done as your provider orders. What is rivaroxaban (Xarelto®)? • Rivaroxaban is also called Xarelto® • Rivaroxaban(Xarelto®) is used to reduce the risk of blood clots and stroke in people with an abnormal heart rhythm known as atrial fibrillation, in people who have had a blood clot, or in people who have undergone orthopedic surgery. o Blood clots can block a blood vessel cutting off blood supply to the area. o Rarely, clots can break into pieces and travel in the blood stream, lodging in the heart (causing a heart attack), the lungs (causing a pulmonary embolus), or in the brain (causing a stroke). • If you were previously on Warfarin/Coumadin® and you are starting Rivaroxaban(Xarelto®), do not continue taking warfarin. Rivaroxaban(Xarelto®) replaces warfarin. Xarelto 10mg tablet Xarelto 15mg tablet Xarelto 20mg tablet How should I take rivaroxaban (Xarelto®)? • Take Rivaroxaban(Xarelto®) exactly as prescribed by your doctor. • Rivaroxaban(Xarelto®) should be taken with food. • Rivaroxaban(Xarelto®) tablets may be crushed and mixed with applesauce to make the tablet easier to swallow. - 1 - • If you missed a dose: o Take it as soon as you remember on the same day. • Do not stop taking rivaroxaban suddenly without telling your doctor. This can put you at risk of having a stroke or a blood clot. • If you take too much rivaroxaban, call your doctor or the anticoagulation service. If you are experiencing any bleeding which you cannot get to stop, go to the nearest emergency room.
    [Show full text]
  • Adasuve, INN-Loxapine
    ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT ADASUVE 4.5 mg inhalation powder, pre-dispensed 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each single-dose inhaler contains 5 mg loxapine and delivers 4.5 mg loxapine. 3. PHARMACEUTICAL FORM Inhalation powder, pre-dispensed (inhalation powder). White device with a mouthpiece on one end and a pull-tab protruding from the other end. 4. CLINICAL PARTICULARS 4.1 Therapeutic indications ADASUVE is indicated for the rapid control of mild-to-moderate agitation in adult patients with schizophrenia or bipolar disorder. Patients should receive regular treatment immediately after control of acute agitation symptoms. 4.2 Posology and method of administration ADASUVE should only be administered in a hospital-setting under the supervision of a healthcare professional. Short-acting beta-agonist bronchodilator treatment should be available for treatment of possible severe respiratory side-effects (bronchospasm). Posology The recommended initial dose of ADASUVE is 9.1 mg. A second dose can be given after 2 hours, if necessary. No more than two doses should be administered. A lower dose of 4.5 mg may be given if the 9.1 mg dose was not previously tolerated by the patient or if the physician decides a lower dose is more appropriate. Patient should be observed during the first hour after each dose for signs and symptoms of bronchospasm. Elderly The safety and efficacy of ADASUVE in patients older than 65 years of age have not been established. No data are available. Renal and/or hepatic impairment ADASUVE has not been studied in patients with renal or hepatic impairment.
    [Show full text]
  • Review of Systems – Clinician Documentation Aug 2019
    Review of Systems – Clinician Documentation Aug 2019 WHAT YOU NEED TO KNOW: Review of Systems (ROS) is an inventory of body systems obtained by asking a series of questions to identify signs and/or symptoms the patient may be experiencing or has experienced. CMS and Payers have varying documentation audit focal points for clinical validation of services rendered. Points are not synonymous with symptoms. What are the systems recognized 1. Constitutional Symptoms (for example: fever, weight loss) for ROS? 2. Eyes 3. Ears, nose, mouth, throat 4. Cardiovascular 5. Respiratory 6. Gastrointestinal 7. Genitourinary What are the three types of ROS? 1. Problem pertinent 2. Extended 3. Complete What is required for each type 1. Problem Pertinent ROS inquires about the system directly related to the problem ROS? identified in the History of Physical Illness (HPI). 2. Extended ROS inquires about the system directly related to the problem(s) identified in the HPI and a limited number (two to nine) of additional systems. 3. Complete ROS inquires about the system(s) directly related to the problem(s) identified in the HPI plus all additional (minimum of ten) organ systems. You must individually document those systems with positive or pertinent negative responses. For the remaining systems, a notation indicating all other systems are negative is permissible. Documentation Requirements Documentation within the patient record should support the level of service billed. For every service billed, you must indicate the specific sign, symptom, or patient complaint that makes the service reasonable and medically necessary. It would be inappropriate and likely ruled not medically necessary to bill based on a full review of systems for a problem focused complaint.
    [Show full text]
  • Pulmonary Vascular Complications of Liver Disease
    American Thoracic Society PATIENT EDUCATION | INFORMATION SERIES Pulmonary Vascular Complications of Liver Disease People who have advanced liver disease can have complications Jaundice that affect the heart and lungs. It is not unusual for a person (yellow tint to skin with severe liver disease to have shortness of breath. Breathing and eyes) problems can occur because the person can’t take as big a breath due to large amounts of ascites (fluid in the abdomen) or pleural effusions (fluid build-up between the tissues that line the lung and chest) or a very large spleen and liver that pushes the diaphragm up. Breathing problems can also occur with Hepatomegaly liver disease from changes in the blood vessels and blood flow in the lungs. There are two well-recognized conditions that can result from liver disease: hepatopulmonary syndrome and portopulmonary hypertension. This fact sheet will review these Breathing two conditions and how they relate to liver disease. problems What is liver disease? the rest of your body. These toxins can damage blood vessels The liver is the second largest organ in the body and has many in your lungs leading to dilated (enlarged) or constricted important roles within the body including helping with digestion, (narrowed) vessels. Two different conditions can be seen in the metabolizing drugs, and storing nutrients. Its main job is to lungs that arise from liver disease: hepatopulmonary syndrome filter blood coming from the digestive tract and remove harmful and portopulmonary hypertension: CLIP AND COPY AND CLIP substances from it before passing it to the rest of the body.
    [Show full text]
  • Types of Chest Pain Table
    Types of Chest Pain This table explains some of the common causes, signs and symptoms of chest pain. Please remember that this information is a guide only. DO NOT USE FOR DIAGNOSIS. If symptoms persist, or you become unsure or concerned, please speak with your doctor. Name Cause of chest pain Symptoms of chest pain Location of pain How to relieve chest pain Angina Angina occurs when there isn't discomfort May be felt in the centre of Rest enough oxygen-rich blood flowing to tightness the chest or across the Anginine – dissolved part of your heart. Angina is caused pressure chest, into the throat or jaw, under the tongue by narrowed coronary arteries. squeezing down the arms, between the or heaviness shoulder blades Nitrolingual spray- dull ache Unstable angina may be sprayed under the unrelated to activity or Additional symptoms may include: tongue stress, comes on more nausea shortness of breath frequently or takes longer to strange feeling or ease tingling/numbness in the Angina symptoms can neck, back, arm, jaw or gradually get worse over 2 to 5 shoulders minutes. Angina usually lasts less light headedness than 15 minutes irregular heart beat Heart Attack A heart attack happens when plaque similar to angina however unable to pinpoint exact A heart attack is a cracks inside the narrowed coronary last longer than 15 minutes spot medical emergency. artery - causing a blood clot to form. and are not relieved by rest, May be felt in the centre of If the blood clot totally blocks the Anginine or Nitrolingual the chest or across the If pain is not relieved by artery, the heart muscle becomes spray chest, into the throat or jaw, Anginine or Nitrolingual damaged Additional symptoms may include: down the arms, between the spray in 10 to 15 minutes, nausea shoulder blades call 000 for an vomiting ambulance.
    [Show full text]